Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-023736

Director sold 10,000 shares at $23.88 ($238,801)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Welgus Howard G. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Sale : show line 1 in the form 10b5-1 −10,000 $23.88 $238,801 39,744 D
Open-market sales · 10,000 sh · avg $23.88 · $238,801
Loading xslF345X06/wk-form4_1775252777.xml…